<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR4">
 <label>4.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Der Meeren</surname>
    <given-names>OV</given-names>
   </name>
   <name>
    <surname>Hatherill</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Nduba</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Wilkinson</surname>
    <given-names>RJ</given-names>
   </name>
   <name>
    <surname>Muyoyeta</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Van Brakel</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis</article-title>
  <source>N Engl J Med</source>
  <year>2018</year>
  <volume>379</volume>
  <fpage>1621</fpage>
  <lpage>1634</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1803484</pub-id>
  <pub-id pub-id-type="pmid">30280651</pub-id>
 </element-citation>
</ref>
